Literature DB >> 23719162

Behavioral effects of cocaine mediated by nitric oxide-GAPDH transcriptional signaling.

Risheng Xu1, Anthony V Serritella, Tanusree Sen, Justin M Farook, Thomas W Sedlak, Jay Baraban, Solomon H Snyder, Nilkantha Sen.   

Abstract

Cocaine's behavioral-stimulant effects derive from potentiation of synaptic signaling by dopamine and serotonin leading to transcriptional alterations in postsynaptic cells. We report that a signaling cascade involving nitric oxide (NO) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mediates cocaine's transcriptional and behavioral actions. Lower, behavioral-stimulant doses enhance the cAMP response element-binding (CREB) signaling system, while higher, neurotoxic doses stimulate the p53 cytotoxic system. The drug CGP3466B, which potently and selectively blocks GAPDH nitrosylation and GAPDH-Siah binding, prevents these actions as well as behavioral effects of cocaine providing a strategy for anticocaine therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719162      PMCID: PMC4047707          DOI: 10.1016/j.neuron.2013.03.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  29 in total

Review 1.  Clinical trials of neuroprotection for Parkinson's disease.

Authors:  Peter A LeWitt
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

2.  TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Authors:  C Warren Olanow; Anthony H V Schapira; Peter A LeWitt; Karl Kieburtz; Dirk Sauer; Gianfranco Olivieri; Harald Pohlmann; Jean Hubble
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

3.  Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import.

Authors:  Makoto Taniguchi; Maria B Carreira; Laura N Smith; Benjamin C Zirlin; Rachael L Neve; Christopher W Cowan
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

4.  An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease.

Authors:  Y Sagot; N Toni; D Perrelet; S Lurot; B King; H Rixner; L Mattenberger; P C Waldmeier; A C Kato
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

Review 6.  Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.

Authors:  P Nigel Leigh; Michael Swash; Yasuo Iwasaki; Albert Ludolph; Vincent Meininger; Robert G Miller; Hiroshi Mitsumoto; Pamela Shaw; Kunio Tashiro; Leonard Van Den Berg
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-06

Review 7.  Brain-derived neurotrophic factor and cocaine addiction.

Authors:  Jacqueline F McGinty; Timothy W Whitfield; William J Berglind
Journal:  Brain Res       Date:  2009-09-02       Impact factor: 3.252

8.  Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.

Authors:  Danielle L Graham; Scott Edwards; Ryan K Bachtell; Ralph J DiLeone; Maribel Rios; David W Self
Journal:  Nat Neurosci       Date:  2007-07-08       Impact factor: 24.884

9.  S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons.

Authors:  Alexi Nott; P Marc Watson; James D Robinson; Luca Crepaldi; Antonella Riccio
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

Review 10.  Involvement of signal transduction cascade via dopamine-D1 receptors in phencyclidine dependence.

Authors:  Yukihiro Noda; Toshitaka Nabeshima
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

View more
  13 in total

1.  Cocaine decreases saccharin preference without altering sweet taste sensitivity.

Authors:  Jennifer K Roebber; Sari Izenwasser; Nirupa Chaudhari
Journal:  Pharmacol Biochem Behav       Date:  2015-03-24       Impact factor: 3.533

Review 2.  Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.

Authors:  Nilkantha Sen
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

3.  Cocaine elicits autophagic cytotoxicity via a nitric oxide-GAPDH signaling cascade.

Authors:  Prasun Guha; Maged M Harraz; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

4.  PARP-1 is required for retrieval of cocaine-associated memory by binding to the promoter of a novel gene encoding a putative transposase inhibitor.

Authors:  E Lax; A Friedman; R Massart; R Barnea; L Abraham; D Cheishvili; M Zada; H Ahdoot; T Bareli; G Warhaftig; L Visochek; M Suderman; M Cohen-Armon; M Szyf; G Yadid
Journal:  Mol Psychiatry       Date:  2016-09-06       Impact factor: 15.992

Review 5.  Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine.

Authors:  Maged M Harraz; Solomon H Snyder
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

6.  Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β.

Authors:  Tanusree Sen; Pampa Saha; Nilkantha Sen
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

Review 7.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

8.  Interactions between N-ethylmaleimide-sensitive factor and GluR2 in the nucleus accumbens contribute to the expression of locomotor sensitization to cocaine.

Authors:  Hai-Feng Lu; Peng-Fei Wu; Yuan-Jian Yang; Wen Xiao; Jun Fan; Jing Liu; Yuan-Long Li; Yi Luo; Zhuang-Li Hu; You Jin; Fang Wang; Jian-Guo Chen
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

Review 9.  Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Trends Pharmacol Sci       Date:  2015-12-17       Impact factor: 14.819

Review 10.  Critical protein GAPDH and its regulatory mechanisms in cancer cells.

Authors:  Jin-Ying Zhang; Fan Zhang; Chao-Qun Hong; Armando E Giuliano; Xiao-Jiang Cui; Guang-Ji Zhou; Guo-Jun Zhang; Yu-Kun Cui
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.